Literature DB >> 11863209

Quality of life in acute exacerbation of chronic bronchitis: results from a German population study.

H Doll1, P Grey-Amante, I Duprat-Lomon, P P Sagnier, I Thate-Waschke, J Lorenz, R Rychlik, T Pfeil.   

Abstract

This study reports on data from a study conducted in the Federal Republic of Germany examining the quality of life (QoL) of patients with chronic bronchitis (CB) and its acute exacerbations (AECB). Data from 320 patients were collected at AECB and subsequently during a stable phase (non-AECB) utilizing the St George's Respiratory Questionnaire (SGRQ) and the Nottingham Health Profile (NHP). As expected, the QoL of CB patients was poor, even at non-AECB, with patients reporting lower scores than patients with other chronic conditions. Patients reported significantly poorer QoL at AECB than at non-AECB. After adjusting for the severity of the underlying condition, poorer QoL at AECB was significantly and independently associated with older age, unemployment, increasing BMI, increasing number of prior AECBs, and Anthonisen AECB grade. While younger subjects reported significantly greater deterioration in QoL at AECB, the factors most consistently and independently associated with relative QoL deterioration at AECB were the number of prior AECBs and exposure to air pollution at home. In conclusion, this study highlights the detrimental effect of CB, and in particular AECB, on QoL. The association between QoL and patient reports of previous AECB number and air pollution are consistent with reports from other studies.

Entities:  

Mesh:

Year:  2002        PMID: 11863209     DOI: 10.1053/rmed.2001.1208

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  [Pelargonium sidoides in acute bronchitis - Health-related quality of life and patient-reported outcome in adults receiving EPs 7630 treatment].

Authors:  Heinrich Matthys; Victor G Lizogub; Petra Funk; Fathi A Malek
Journal:  Wien Med Wochenschr       Date:  2010-12

2.  Real-life treatment of acute exacerbations of chronic bronchitis with moxifloxacin or macrolides: a comparative post-marketing surveillance study in general practice.

Authors:  T Schaberg; M Möller; T File; K Stauch; H Landen
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 3.  Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature.

Authors:  Helen Doll; Marc Miravitlles
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 4.  The quality of life impact of acute exacerbations of chronic bronchitis (AECB): a literature review.

Authors:  Jordana K Schmier; Michael T Halpern; Mitchell K Higashi; Alan Bakst
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

5.  Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study.

Authors:  M Miravitlles; M Ferrer; A Pont; R Zalacain; J L Alvarez-Sala; F Masa; H Verea; C Murio; F Ros; R Vidal
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

6.  Efficacy and tolerability of moxifloxacin in 2338 patients with acute exacerbation of chronic bronchitis.

Authors:  J Barth; H Landen
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

Review 7.  Acute exacerbations of chronic bronchitis in elderly patients: pathogenesis, diagnosis and management.

Authors:  Don Hayes; Keith C Meyer
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Speed of recovery from acute exacerbations of chronic obstructive pulmonary disease after treatment with antimicrobials : results of a two-year study.

Authors:  Marc Miravitlles; Rafael Zalacain; Cristina Murio; Montserrat Ferrer; José L Alvarez-Sala; Juan F Masa; Héctor Verea; Fernando Ros; Rafael Vidal
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

9.  Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profile.

Authors:  Helen Doll; Isabelle Duprat-Lomon; Erika Ammerman; Pierre-Philippe Sagnier
Journal:  Qual Life Res       Date:  2003-03       Impact factor: 4.147

10.  Daily-practice treatment of acute exacerbations of chronic bronchitis with moxifloxacin in a large cohort in Germany.

Authors:  H Koch; H Landen; K Stauch
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.